Experience
Collective experience, presented as evidence
A summary of the areas our experts have worked in, the phases they have supported and their scientific contribution. Sponsors, product names and confidential details are deliberately omitted.
I to IV
Trial phases led and supported by our experts
10+
Years of clinical research experience per advisor
Global
Multicountry studies and international collaborations
Multiple
Institutional collaborations across our team
Areas of collective experience
The expertise our group brings to a clinical development program.
Phase I to IV clinical trials
Study conduct and oversight across the full development sequence.
International clinical research
Multicountry studies with distributed sites and varied infrastructure.
Medical strategy
Clinical rationale, endpoint selection and development sequencing.
Clinical operations
Feasibility, start-up, enrollment and vendor performance.
Clinical program management
Governance, timelines, deliverables and risk management.
Global health
Neglected and infectious disease research with international partners.
Scientific advisory
Independent assessment for boards, investors and management teams.
Regulatory support
Submissions, authority questions, amendments and ethics committee responses.
Training
Clinical research methodology and ICH-GCP for sponsors, sites and academic groups.
Public health
Work with ministries, health services and guideline development.
International collaboration
Programs run jointly across institutions, countries and funders.
Clinical trial involvement
Our collective involvement summarized by development phase and disease area, presented without confidential information.
| Phase | Scope of involvement | Disease areas |
|---|---|---|
| Phase I | First in human design, protocol review, safety oversight and dose escalation support | Infectious disease, vaccines, specialty programs |
| Phase II | Endpoint definition, medical monitoring, feasibility and study conduct | Infectious and neglected disease, vaccines |
| Phase III | Multicountry oversight, investigator and study physician roles, patient safety leadership | Vector-borne and tropical disease, vaccines, infectious disease |
| Phase IV | Post approval research, program oversight and evidence for guidelines and health authorities | Public health and infectious disease |
Sponsor and product information is confidential.
Scientific contributions
Publications
Peer-reviewed articles in clinical and public health research.
Presentations
Oral and poster presentations of study results and methodology.
Congresses
Participation in national and international scientific congresses.
Teaching
University teaching and continuing education for physicians.
Guideline development
Contribution to Colombian clinical practice guideline work.
Training programs
Clinical research and ICH-GCP programs delivered across Latin America.
Publication records for individual experts are available on request.
Engagements are scoped to a defined question or a defined phase of work. Some companies need a development plan they can defend in front of a board. Others need a team accountable for the study while it runs.
Book an introductory conversation